<DOC>
	<DOCNO>NCT01958957</DOCNO>
	<brief_summary>The aim study evaluate safety Ginkgolides Meglumine Injection treatment ischemic stroke Syndrome Intermingled Phlegm Blood Stasis .</brief_summary>
	<brief_title>A Safety Study Ginkgolides Meglumine Injection Treatment Ischemic Stroke .</brief_title>
	<detailed_description>Ginkgolides Meglumine Injection jointly develop China Pharmaceutical University Jiangsu Kanion Pharmaceutical Co. , Ltd. Its pharmacal ingredient ginkgo lactones , ginkgo lactone B , ginkgo lactone K , etc ; Excipients meglumine , citric acid , sodium chloride . It use treat stroke ( mild-to-moderate cerebral infarction ) recovery phlegm Syndrome Intermingled Phlegm Blood Stasis . The aim study evaluate safety Ginkgolides Meglumine Injection treatment ischemic stroke Syndrome Intermingled Phlegm Blood Stasis .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>patient accord diagnostic standard western medical ischemic stroke ; patient accord diagnostic standard Chinese medical attack meridian ; patient accord differentiation standard syndrome intermingled phlegm blood stasis ; 2 week 6 month attack ; Age 1880 year ; patient must volunteer participate study sign inform consent form . patient accompany unconsciousness severe dementia ; ALT , AST≥2 time upper limit normal ; patient severe disease disease circulatory system , hematopoietic system , digestive system , endocrine system etc ; patient allergic Ginkgo biloba drugs，Meglumine meglumine agent ; patient pregnant , lactate planning pregnancy ; patient insanity ; patient suitable clinical trial doctor ' consideration ; patient Merge bleed infarction patient hemorrhagic tendency ; patient low extremity venous thrombosis ; patient participate clinical trial within 1 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>safety</keyword>
	<keyword>Ginkgolides Meglumine Injection</keyword>
</DOC>